A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Misoprostol
Ramiprilat
The risk or severity of adverse effects can be increased when Everolimus is combined with Ramiprilat.
Misoprostol
Fosinoprilat
The risk or severity of adverse effects can be increased when Everolimus is combined with Fosinoprilat.
Misoprostol
Benazeprilat
The risk or severity of adverse effects can be increased when Everolimus is combined with Benazeprilat.
Misoprostol
Delapril
The risk or severity of adverse effects can be increased when Everolimus is combined with Delapril.
Misoprostol
Zofenopril
The risk or severity of adverse effects can be increased when Everolimus is combined with Zofenopril.
Misoprostol
Imidapril
The risk or severity of adverse effects can be increased when Everolimus is combined with Imidapril.
Misoprostol
Enalaprilat
The risk or severity of adverse effects can be increased when Everolimus is combined with Enalaprilat.
Misoprostol
Temocapril
The risk or severity of adverse effects can be increased when Everolimus is combined with Temocapril.
Misoprostol
Rescinnamine
The risk or severity of adverse effects can be increased when Everolimus is combined with Rescinnamine.
Misoprostol
Armodafinil
The metabolism of Everolimus can be increased when combined with Armodafinil.
Misoprostol
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Everolimus.
Misoprostol
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Everolimus.
Misoprostol
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Everolimus.
Misoprostol
Roflumilast
Roflumilast may increase the immunosuppressive activities of Everolimus.
Misoprostol
Ixabepilone
The risk or severity of adverse effects can be increased when Everolimus is combined with Ixabepilone.
Misoprostol
Idelalisib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Everolimus.
Misoprostol
Tetrandrine
The risk or severity of adverse effects can be increased when Everolimus is combined with Tetrandrine.
Misoprostol
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Everolimus is combined with Hydroxychloroquine.
Misoprostol
Cabazitaxel
The risk or severity of adverse effects can be increased when Everolimus is combined with Cabazitaxel.
Misoprostol
Vilanterol
The risk or severity of adverse effects can be increased when Everolimus is combined with Vilanterol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3